







NeuroLF System
Brain Positron Emission Tomography System
Positrigo
Dementia and Alzheimer’s disease is a worldwide problem for which proper diagnosis is critical to offer individualized treatment. Positron Emission Tomography (PET) is considered the gold standard to diagnose Alzheimer’s disease but today’s PET devices are large and expensive preventing its broad availability. Our dedicated brain PET system NeuroLF is small and offers an unmet price-value proposition to allow for wide adoption and application. Beside a significant initial addressable market, future NeuroLF applications will allow for attractive revenue growth and addresses a huge socio-economic problem at the same time.
Client / ManufacturerDesign
Positrigo
Zürich, CHSanmina
Örnsköldsvik, SEHelbling Technik AG
Zürich, CHLennart BehrmannDate of Launch
2024
Development Time
more than 24 Month
Target Regions
Asia, Europe, North America, South America
Target Groups
"Hospitals and Neurology Offices"